Decellularised spinal cord matrix manipulates glial niche into repairing phase via serglycin‐mediated signalling pathway
Sheng Zhang,Man Zhai,Yiwei Xu,Jiandong Han,Jiaxin Chen,Yucui Xiong,Shihua Pan,Qizheng Wang,Chunlai Yu,Zilong Rao,Qi Sun,Yufei Sui,Ke Fan,Heying Li,Wenjing Guo,Cuicui Liu,Ying Bai,Jing Zhou,Daping Quan,Xiao Zhang
DOI: https://doi.org/10.1111/cpr.13429
IF: 8.755
2023-02-20
Cell Proliferation
Abstract:Astrocytes play an essential role in spinal cord injury repair. However, the glial niche alterations during the extracellular matrix‐mediated repairing process concerning the decellularised spinal cord matrix (DSCM) regulatory mechanisms have not been clarified. In this study, we demonstrated that DSCM increased the proportion of differentiated neural progenitor cell subtypes in the migrated heterogeneous cell population of a spinal cord organotypic model, and this increase was correlated with a rise in immature astrocyte subtypes through ligand–receptor interactions. In addition, as a defined functional component of DSCM, which caused upregulated mesenchymal‐related gene expression via the serglycin (SRGN)‐mediated CD44–AKT signalling pathway. Thus, this SRGN‐mediated pathway sustained human spinal cord‐derived primary astrocytes in an immature status, reducing cytokine receptors' expression with declined response to inflammatory stimuli. Finally, we verify that defined SRGN‐COLI and DSCM had similar functions in the human primary cell co‐culture system to regulate astrocyte and endothelial cell subtypes in altering the glial niche into the repairing phase. Astrocytes are the most abundant and widespread glial cells in the central nervous system. The heterogeneity of astrocytes plays an essential role in spinal cord injury (SCI) repair. Decellularised spinal cord matrix (DSCM) is advantageous for repairing SCI, but little is known regarding the exact mechanisms and niche alterations. Here, we investigated the DSCM regulatory mechanism of glial niche in the neuro‐glial‐vascular unit using single‐cell RNA sequencing. Our single cell sequencing, molecular and biochemical experiments validated that DSCM facilitated the differentiation of neural progenitor cells through increasing the number of immature astrocytes. Upregulation of mesenchyme‐related genes, which maintained astrocyte immaturity, causing insensitivity to inflammatory stimuli. Subsequently, we identified serglycin (SRGN) as a functional component of DSCM, which involves inducing CD44–AKT signalling to trigger human spinal cord‐derived primary astrocytes (hspASCs) proliferation and upregulation of genes related to epithelial–mesenchymal transition, thus impeding astrocyte maturation. Finally, we verified that SRGN‐COLI and DSCM had similar functions in the human primary cell co‐culture system to mimic the glia niche. In conclusion, our work revealed that DSCM reverted astrocyte maturation and altered the glia niche into the repairing phase through the SRGN‐mediated signalling pathway.
cell biology